Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"
23/02/24 Institute of Biomedical Research Corp. Introduces M2BioKids CI
30/01/24 Real American Capital Corp. acquired M2MMA from Institute of Biomedical Research Corp.. CI
12/10/23 Institute of Biomedical Research Corp. Appoints Victor Lange as CEO of M2MMA CI
21/09/23 Institute of Biomedical Research Corp. acquired JDAX. CI
13/09/23 Institute of Biomedical Research Corp. Presents Update on its Latest Scientific Endeavor: M2Bio Sciences Endeavors to Usher in a Paradigm Shift Within the Realm of Medical Health by Focusing on the Foundational Facet of Drug Discovery CI
13/09/23 Institute of Biomedical Research Corp. Appoints Ze-Ev Krein, an Interdisciplinary Scientist, and M2bio Scientific Advisory Board Chairman CI
17/07/23 Institute of Biomedical Research Corp. Unveils a Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits CI
27/06/23 Institute of Biomedical Research Corp. signed a letter of intent to acquire JDAX. CI
16/06/23 Institute of Biomedical Research Corp. Establishes Research Chair At the University of Pretoria for Phytomedicines CI
18/07/22 Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN). CI
27/01/15 Institute of Biomedical Research Corp. acquired Travel Mix Group Inc. CI
28/04/14 Neuro-Biotech Corp. will Change its Name to The Institute of Biomedical Research Corp CI
31/01/14 Institute of Biomedical Research acquired Neuro-Biotech Corp. in a reverse merger transaction. CI
1 week-25.00%
Current month-29.41%
3 months-25.00%
6 months-78.18%
Current year-57.14%
1 week 0
Extreme 0.0011
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0007
0.01
1 year 0
Extreme 0.0007
0.02
3 years 0
Extreme 0.0001
0.03
5 years 0
Extreme 0.0001
0.04
10 years 0
Extreme 0.0001
0.04
Manager TitleAgeSince
Chief Executive Officer - 11/07/2022
Director of Finance/CFO 68 -
Chief Tech/Sci/R&D Officer - 25/11/2024
Director TitleAgeSince
Director/Board Member - 11/07/2022
Director/Board Member 68 -
Date Price Change Volume
11/06/26 0.001200 $ 0.00% 725,000
10/06/26 0.001200 $ -14.29% 2,950,000
09/06/26 0.001400 $ -6.67% 100,000
08/06/26 0.001500 $ -6.25% 10,400
05/06/26 0.001600 $ 0.00% 3,385,000
  1. Stock Market
  2. Stocks
  3. MRES Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!